Based on its innovative MedTech platform for personalized patient support, Nia Health develops medical software. Nia Health’s end-to-end solutions are indication-specific and tailored to the individual needs of each patient.

Nia Health covers a wide variety of use cases in the dermatology and allergology space. Nia Health’s Digital Therapeutics (DTx) combine strong clinical validation with empowerment, gamification, and machine learning.

It is Nia Health’s mission to provide a highly engaging and personalized patient experience that removes barriers to health behavior change.

The award-winning eczema app Nia is the most used medical eczema app in Europe and was the first app of its kind to be approved as a medical device. Six months after its release in 2019, it was already reimbursed by Germany’s third-largest health insurance company.

Another product, the psoriasis app Sorea, was launched in 2020 and is the first psoriasis app approved as a medical device. The third app, milderma, supports patients with chronic acne and is also the first acne app approved as a medical device.

Nia Health provides platform-based Digital Therapeutics (DTx) development, remote patient monitoring, and digital trial tools as key services. Their technology supports healthcare providers in delivering personalized care and real-time medical information access.